Reference health

Vascular aspects of multiple sclerosis

https://doi.org/10.1016/s1474-4422(11)70105-3
CiteStamped reference-health badge
93/93 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

13 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 93 checked references that resolve
resolves10.1056/NEJM200009283431307
Multiple Sclerosis
resolves10.1212/WNL.43.9.1760
Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada
resolves10.1016/S0303-8467(02)00036-7
The worldwide prevalence of multiple sclerosis
resolves10.1007/s100720070020
Age at onset in multiple sclerosis
resolves10.1001/archneur.61.10.1613
Multiple Sclerosis Is an Inflammatory T-Cell–Mediated Autoimmune Disease
resolves10.1056/NEJMra052130
Multiple Sclerosis — The Plaque and Its Pathogenesis
resolves10.1212/WNL.41.8.1193
Cause of death in patients attending multiple sclerosis clinics
resolves10.1136/jnnp.50.5.523
Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
resolves10.1016/0021-9681(83)90163-7
Underlying cause of death as recorded for multiple sclerosis patients: Associated factors
resolves10.1111/j.1600-0404.1985.tb03194.x
Multiple sclerosis and mortality statistics
resolves10.1136/jnnp.65.1.56
Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry
resolves10.1093/brain/awh104
Trends in survival and cause of death in Danish patients with multiple sclerosis
resolves10.1136/jnnp.2007.127332
Survival and cause of death in multiple sclerosis: a prospective population-based study
resolves10.1159/000128103
Vascular Disease among Hospitalized Multiple Sclerosis Patients
resolves10.1159/000320245
Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study
resolves10.1016/0895-4356(94)90099-X
Patterns of comorbidity in elderly patients with multiple sclerosis
resolves10.1093/aje/154.1.69
Cigarette Smoking and Incidence of Multiple Sclerosis
resolves10.1056/NEJM199901143400207
Atherosclerosis — An Inflammatory Disease
resolves10.1056/NEJM200003233421202
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
resolves10.1016/j.autrev.2010.07.016
From endothelial dysfunction to atherosclerosis
resolves10.1186/ar3116
Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness
resolves10.1111/j.1756-185X.2010.01480.x
Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis
resolves10.1212/WNL.56.10.1319
Elevated plasma endothelial microparticles in multiple sclerosis
resolves10.1016/j.jocn.2007.02.090
Coagulation status and biochemical and inflammatory markers in multiple sclerosis
resolves10.1186/1742-2094-5-27
Evidence of platelet activation in multiple sclerosis
resolves10.1161/01.RES.87.10.840
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
resolves10.1007/s00415-005-0037-3
Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis
resolves10.1177/1352458510384010
Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by <sup>1</sup> H magnetic resonance chemical shift imaging at 3 T
resolves10.1186/1742-2094-7-23
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
resolves10.1007/s10545-010-9177-4
Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects
resolves10.1177/1352458506075503
Increased plasma homocysteine levels in multiple sclerosis
resolves10.1007/s00415-007-0668-7
Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis
resolves10.1136/jnnp.2005.072199
Plasma homocysteine levels in multiple sclerosis
resolves10.1152/ajpendo.00367.2010
Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia
resolves10.2478/s11658-010-0040-2
Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro
resolves10.1016/j.jns.2007.02.011
Cerebral blood perfusion changes in multiple sclerosis
resolves10.1136/jnnp.47.11.1182
Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.
resolves10.1159/000116926
Regional Cerebral Blood Flow in Multiple Sclerosis Measured by Single Photon Emission Tomography with Technetium-99m Hexamethyl-propyleneamine Oxime
resolves10.1080/01616412.1983.11739631
Cerebral Blood Flow and Red Cell Delivery in Normal Subjects and in Multiple Sclerosis
resolves10.1007/BF03164835
Clinical significance of reduced cerebral metabolism in multiple sclerosis: A combined PET and MRI study
resolves10.1148/radiol.2313030996
Microvascular Abnormality in Relapsing-Remitting Multiple Sclerosis: Perfusion MR Imaging Findings in Normal-appearing White Matter
resolves10.1016/j.neuroimage.2006.08.008
Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T
resolves10.1161/01.STR.21.12.1694
Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type.
resolves10.1016/j.jns.2008.12.036
White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis
resolves10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S
Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction
resolves10.1093/brain/awh007
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study
resolves10.1038/jcbfm.2008.72
Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance
resolves10.1111/j.1582-4934.2006.tb00289.x
Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions
resolves10.1111/j.1469-7793.1998.199br.x
Regulation of arterial diameter and wall [Ca<sup>2+</sup>] in cerebral arteries of rat by membrane potential and intravascular pressure
resolves10.1212/WNL.53.8.1628
Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors
resolves10.1371/journal.pone.0010811
Reduced Creatine Kinase B Activity in Multiple Sclerosis Normal Appearing White Matter
resolves10.1002/glia.20384
Regulation of the astrocyte resting membrane potential by cyclic AMP and protein kinase A
resolves10.1097/00041327-200103000-00011
Increased Endothelin-1 Plasma Levels in Patients With Multiple Sclerosis
resolves10.1159/000069085
Extraocular Blood Flow and Endothelin-1 Plasma Levels in Patients with Multiple Sclerosis
resolves10.1093/jnen/62.1.25
Preferential Loss of Myelin-Associated Glycoprotein Reflects Hypoxia-Like White Matter Damage in Stroke and Inflammatory Brain Diseases
resolves10.1111/j.1750-3639.2003.tb00485.x
Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult
resolves10.1038/nrn1408
HIF1 and oxygen sensing in the brain
resolves10.1161/01.STR.0000221308.94473.14
White Matter Lesions in an Unselected Cohort of the Elderly
resolves10.1046/j.1471-4159.2003.01674.x
Oligodendrocyte injury in multiple sclerosis: a role for p53
resolves10.1007/s12264-010-1111-0
p53-mediated neuronal cell death in ischemic brain injury
resolves10.1136/jnnp.69.1.48
Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI
resolves10.1016/j.jns.2005.06.018
Subcortical vascular cognitive impairment: Similarities and differences with multiple sclerosis
resolves10.1038/sj.jcbfm.9600504
Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis
resolves10.1016/j.brainresrev.2004.04.005
Physiology of cerebral venous blood flow: from experimental data in animals to normal function in humans
resolves10.1016/S0140-6736(99)04804-7
Postural dependency of the cerebral venous outflow
resolves10.1113/jphysiol.2004.070409
Human cerebral venous outflow pathway depends on posture and central venous pressure
resolves10.1136/jnnp.2008.157164
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
resolves10.1258/phleb.2010.009083
The chronic cerebrospinal venous insufficiency syndrome
resolves10.1186/1471-2350-11-64
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis
resolves10.1212/WNL.0b013e318212a901
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
resolves10.1002/ana.22085
No cerebrocervical venous congestion in patients with multiple sclerosis
resolves10.1007/s00115-010-2972-1
„Chronische zerebrospinale venöse Insuffizienz“ und Multiple Sklerose
resolves10.1136/jnnp.2010.231613
The perfect crime? CCSVI not leaving a trace in MS
resolves10.1002/ana.22228
No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset
resolves10.1002/ana.22159
Multiple sclerosis appears To be associated with cerebral venous abnormalities
resolves10.1002/ana.22132
Venous and cerebrospinal fluid flow in multiple sclerosis: A case‐control study
resolves10.1136/jnnp.2010.223479
No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study
resolves10.3174/ajnr.A2386
Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: A Pilot Longitudinal Study
resolves10.1038/jcbfm.2009.180
Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis
resolves10.1016/j.arr.2004.03.001
Iron and ageing: an introduction to iron regulatory mechanisms
resolves10.1016/j.nurt.2007.05.006
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
resolves10.1007/s00109-006-0065-1
Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain
resolves10.1196/annals.1306.021
The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis
resolves10.1111/j.1750-3639.2007.00064.x
The Immunopathology of Multiple Sclerosis: An Overview
resolves10.3233/JAD-2009-1010
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
resolves10.1002/ana.22001
Chronic cerebrospinal venous insufficiency and multiple sclerosis
resolves10.1177/1352458510385268
Extracranial venous stenosis is an unlikely cause of multiple sclerosis
resolves10.1016/j.jvs.2009.07.096
A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency
resolves10.1186/1741-7015-9-22
Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report
resolves10.1152/jappl.1954.7.3.245
<i>Effect of Increased Jugular Pressure on Cerebral Hemodynamics</i>
resolves10.1016/0022-4804(79)90085-4
The effects of primary elevation of cerebral venous pressure on cerebral hemodynamics and intracranial pressure
resolves10.1002/jmri.21758
Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility‐weighted imaging at 3.0 Tesla
resolves10.1007/s00270-010-0050-5
Cardiovascular and Interventional Radiological Society of Europe Commentary on the Treatment of Chronic Cerebrospinal Venous Insufficiency
The 13 references without a DOI — listed, not checked
no DOI — not checkedT-cell agents in the treatment of rheumatoid arthritis
no DOI — not checkedDynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity
no DOI — not checkedDiffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis
no DOI — not checkedCorrelation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis
no DOI — not checkedEndothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis
no DOI — not checkedHemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course
no DOI — not checkedExtracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis
no DOI — not checkedInternal jugular vein morphology and hemodynamics in patients with multiple sclerosis
no DOI — not checkedUse of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls
no DOI — not checkedIron stores and cerebral veins in MS studied by susceptibility weighted imaging
no DOI — not checkedChronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study
no DOI — not checkedIron deposits surrounding multiple sclerosis plaques
no DOI — not checkedIs chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/s1474-4422(11)70105-3"><img src="https://citestamp.com/citestamped/10.1016/s1474-4422(11)70105-3/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/s1474-4422(11)70105-3/badge.svg)](https://citestamp.com/citestamped/10.1016/s1474-4422(11)70105-3)